Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc.

6. Vet check-ups Dr. MacMillan says, "Regular check-ups with the vet will help to ensure your cat is maintaining a healthy ...

Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial, boosting the company’s standing in the fast-growing market for weight loss and diabetes ...

The health secretary said he would prioritize studies into environmental causes while harshly discounting other factors ...

For generations, the pot belly in India has been more than just a physical attribute ~ it has been a symbol.

During Abu Dhabi Global Health Week (ADGHW), the Abu Dhabi Public Health Centre (ADPHC) and the McKinsey Health Institute of ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

Nasdaq pressured by tech losses, S&P 500 vulnerable. Google faces DOJ breakup risk, while traders brace for Netflix earnings ...

China just hit back in the escalating trade war — and Trump’s strategy may be on shaky ground As tariffs skyrocket and tensions rise, both superpowers are digging in Is Trump’s high-stakes gamble ...